华领医药-B（02552）于2026年3月5日发布截至2026年2月28日的股份变动月报。报告显示，公司法定股本仍为2,000,000,000股，每股面值0.001美元，法定股本总额2,000,000美元，与上月无异。
公司普通股于报告期末的已发行股份数为1,056,605,016股，未见新增发行、购回或注销记录，且无库存股。期权方面，一项于2018年通过并生效的股份期权计划当月注销100,000份期权，期末剩余股份期权数为79,139,669份，上月底可行使股份期权数量为15,107,033股。期权注销并未导致当月任何实际股份增发。
公司确认已遵守香港联合交易所有限公司的上市规则及相关法律规定。截至2026年2月28日，华领医药-B总股本保持稳定，公告由公司秘书袁颖欣签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.